Attenuated Subcomponent Vaccine Design Targeting the SARS-CoV-2 Nucleocapsid Phosphoprotein RNA Binding Domain: In Silico Analysis

Table 3

MHC-I epitopes of SARS-CoV-2 NP.

S/N	Start	End	Peptide	Length	Alleles	Antigenicity	Toxicity	Allergenicity
1	222	230	LLLDRLNQL	9	HLA-A02:01, HLA-C03:02, HLA-C01:02, HLA-A30:01, HLA-B07:02, HLA-A01:01, HLA-B35:01, HLA-A03:01	0.1566	Nontoxic	Nonallergen
2	316	324	GMSRIGMEV	9	HLA-A02:01, HLA-C01:02, HLA-C03:02, HLA-A30:01, HLA-A01:01, HLA-A03:01, HLA-B07:02, HLA-B35:01	0.6287	Nontoxic	Nonallergen
3	331	339	LTYTGAIKL	9	HLA-A02:01, HLA-C01:02, HLA-C03:02, HLA-A30:01, HLA-A01:01, HLA-A03:01, HLA-B07:02, HLA-B35:01	0.6524	Nontoxic	Nonallergen
4	406	414	QLQQSMSSA	9	HLA-A03:01, HLA-B07:02, HLA-B35:01	0.3180	Nontoxic	Nonallergen

Selected CTL epitope. Selected epitopes are tagged as C2 and C3.